It has been reported that endothelin-1 (ET-1) increases in acute myocardial infarction (AMI).
Experimental studies showed that captopril administration reduces ET-1 secretion. In …

Studies showed that endothelin-1 (ET-1) was increased in the acute myocardial infarction
(AMI). Experimental studies reported that captopril was able to reduce ET-1 secretion, and …

The aim of this study was to investigate the behavior of plasma endothelin-1 (ET-1) in 23
patients with acute myocardial infarction, complicated and uncomplicated by left ventric ular …

Background The aim of the present study was to investigate the relationship between
plasma concentrations of endothelin (ET)-1 and clinical outcome (including mortality) and …

An elevated plasma level of endothelin-1 was reported in several cardiovascular conditions
including unstable angina pectoris and myocardial infarction. The present study was …

The key role of endothelin-1 (ET-1) has been recognised in patients with ischaemic heart
disease. However, the serial changes of ET-1 during both brief and prolonged ischaemia …

Endothelin is a novel endothelium-derived vasoactive peptide with potent vasoconstrictor
action in the coronary bed; however, its possible contribution to myocardial ischemia and …

Plasma levels of endothelin-1 are elevated in acute myocardial infarction with higher levels
in complicated infarctions. Measurements of levels in unstable angina could help clarify …

BACKGROUND--Among patients with independent evidence of coronary disease and
recent onset unstable angina or non-Q wave myocardial infarction the incidence of …

Background It has been documented that an elevated endothelin-1 (ET-1) plasma
concentration is associated with an increased risk of serious coronary events and the …